Initiating, Intensifying, and De-intensifying Insulin Webinar

Did you miss the American Diabetes Association®’s live webinar on Initiating, Intensifying and De-intensify Insulin?
Watch diabetes experts, Marisa Rowen, PharmD, CDCES; Kevin Pantalone, DO, ECNU, FACE; and Alison Evert, MS, RDN, CDCES, as they share best practices for initiating, intensifying and de-intensifying insulin in patients with type 2 diabetes. The panelists represented federally qualified health centers, primary care practices, and large-scale health systems. Regardless of where you practice, you will gain insights on:
* creating workflows
* leveraging team-based care,
* avoiding pitfalls to identifying the right patient at the right time with the right dose, and
* recognizing how to overcome barriers to care.
Watch at your own pace. Gain valuable insights. Make a difference in the lives of people with diabetes!
The Overcoming Therapeutic Inertia initiative is supported in part by Novo Nordisk and Sanofi Diabetes.
For more information, visit therapeuticinertia.diabetes.org.

[@biswalashis123]

Dr Kevin's talk was most interesting. EL RIO was more like an advertisement. Plz discuss more case based discussions.

[@chellepatino1675]

I would say that moving basal to the morning actually may help. Basaglar actually has a peak of about 12 hours in some people. It's 18 to 24 hours duration not 24 hours.

[@syedriyazahmad9047]

Nice discussion by experts. Thank you

[@ricecakke]

Which agents are used for post meals blood sugar

[@chellepatino1675]

Glp1s, sglt2 and bolus insulin